Zeo ScientifiX (ZEOX) EBITDA (2012 - 2026)

Zeo ScientifiX has reported EBITDA for 15 years, with the latest figure at -$512000.0 in Q2 2026.

• On a quarterly basis, EBITDA rose 63.27% year-over-year to -$512000.0 in Q2 2026; TTM through Apr 2026 was -$4.1 million, a 21.2% increase from a year earlier, with the FY2025 full-year figure at -$5.4 million, down 1.26% from the prior year.
• EBITDA was -$512000.0 for Q2 2026 at Zeo ScientifiX, up from -$878000.0 in the prior quarter.
• The five-year high for EBITDA was -$512000.0 in Q2 2026, with the low at -$3.2 million in Q4 2022.
• Average EBITDA over 5 years is -$1.5 million, with a median of -$1.4 million recorded in 2024.
• The largest YoY upside for EBITDA was 79.9% in 2022 against a maximum downside of 233.99% in 2022.
• Over 5 years, EBITDA stood at -$3.2 million in 2022, then jumped by 61.27% to -$1.2 million in 2023, then fell by 15.67% to -$1.4 million in 2024, then surged by 53.12% to -$668000.0 in 2025, then grew by 23.35% to -$512000.0 in 2026.
• The last three EBITDA figures came in at -$512000.0 (Q2 2026), -$878000.0 (Q1 2026), and -$668000.0 (Q4 2025), per Business Quant data.